Treatment of hepatorenal syndrome octreotide vs. midodrine vs. norepinephrine as part of triple therapy /
Osman Mohamed Osman
Treatment of hepatorenal syndrome octreotide vs. midodrine vs. norepinephrine as part of triple therapy / علاج متلازمة الفشل الكبدى الكلوى مقارنة بين أوكتريوتايد : ميدودرين ونوابينفرين كجزء من العلاج الثلاثى Osman Mohamed Osman ; Supervised Fahim Ragab , Mohamed Elshafie , Ayman Moharram - Cairo : Osman Mohamed Osman , 2012 - 85Leaves : charts ; 30cm
Thesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of Critical Care Medicine
Hepatorenal syndrome is a serious complication of liver cirrhosis . Splanchnic vasodilatation is the main pathology . Vasoconstrictors are used as treatment aiming at reversal of renal dysfunction . Thirty patients with hepatorenal syndrome were randomized into three groups each receiving albumin , dopamine (nephrogenic dose) and vasoconstrictor (norepinephrine , midodrine or octreotide)
Hepatorenal syndrome Midodrine Vasoconstrictors
Treatment of hepatorenal syndrome octreotide vs. midodrine vs. norepinephrine as part of triple therapy / علاج متلازمة الفشل الكبدى الكلوى مقارنة بين أوكتريوتايد : ميدودرين ونوابينفرين كجزء من العلاج الثلاثى Osman Mohamed Osman ; Supervised Fahim Ragab , Mohamed Elshafie , Ayman Moharram - Cairo : Osman Mohamed Osman , 2012 - 85Leaves : charts ; 30cm
Thesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of Critical Care Medicine
Hepatorenal syndrome is a serious complication of liver cirrhosis . Splanchnic vasodilatation is the main pathology . Vasoconstrictors are used as treatment aiming at reversal of renal dysfunction . Thirty patients with hepatorenal syndrome were randomized into three groups each receiving albumin , dopamine (nephrogenic dose) and vasoconstrictor (norepinephrine , midodrine or octreotide)
Hepatorenal syndrome Midodrine Vasoconstrictors